In pivotal clinical trials for Wegovy, nausea was reported by approximately 44% of patients, while Ozempic trials reported nausea in 15-20% of participants
These additional effects are one of the main reasons semaglutide is considered a revolutionary tool for treating and managing obesity and related issues
But I think its still an open question about their effect on cancer. These drugs include semaglutide (sold under the brand names Ozempic, Wegovy and Rybelsus) and tirzepatide (brand names Mounjaro and Zepbound)
But they can help you reach a better weight baseline
A higher proportion of patients treated with tirzepatide achieved weight loss of 5% or greater (96% vs approximately 86%), 10% or greater (90% vs ~69%), and 15% or greater (78% vs ~50%)
If youre ready to take control of your weight and transform your life, book your consultation with our weight loss expert today